drugset / Trial / NCT01919892
Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium
NaSingle-groupOpen-labelTreatment
Summary
Thirty subjects with a DSM-IV (Diagnostic and Statistical Manual, fourth version)diagnosis of BPD during a depressive or hypomanic episode will be divided in two groups according to age and time of illness. All patients will receive lithium (flexible therapeutic dose) for 6 weeks and improvement will be evaluated weekly using depression and mania rating scales; this study also objectives to identify state/trait markers and predictors of response.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium | Unknown | 450 mg | — |
| Subject | Lithium | Unknown | 900 mg | — |